fda glp-1 compounding warning letters october 2025 issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compound versions of GLP-1 drugs

Patients with certain GLP1R rs6923761 genotypes, for example, may show greater sensitivity to early appetite suppression and metabolic acceleration, which can amplify thermoregulation adjustments

Early lactation (first 6 months) carries higher transfer risk due to increased milk protein content and intestinal permeability in newborns

Why We Need to Change the Way We Talk About GLP-1 Medications After talking with Summer, it really solidified the fact that we need to approach the topic of GLP-1s and obesity with more nuance and less judgement in our society

And maybe a little glutathione

A beneficial and refreshing calorie-free lemonade without sugar

We have lawsuits